Description
The recombinant anti-OPGL monoclonal antibody presents higher affinity than existing alpha OPGL-1 monoclonal antibodies and can be used for preparing medicine for treating bone scarcity, inflammation accompanied by bone loss of patients and autoimmune diseases accompanied by bone loss of patients.
Target
TNFSF11
Target Alias Names
TNF Superfamily Member 11, Tumor Necrosis Factor (Ligand) Superfamily, Member 11, TNF-Related Activation-Induced Cytokine, Osteoclast Differentiation Factor, Osteoprotegerin Ligand, TRANCE, RANKL, OPGL, ODF, Receptor Activator Of Nuclear Factor Kappa B Ligand, Receptor Activator Of Nuclear Factor Kappa-B Ligand
Isotype/Mimetic
Human IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression